Genomic Triangulation and Coverage Analysis in Whole-Exome Sequencing–Based Molecular Autopsies
Authors:
- Garrett W. ShanksGSGarrett W. Shanks
- David J. TesterDTDavid J. Tester
- Sneha NishtalaSNSneha Nishtala
- Jared M. EvansJEJared M. Evans
- Michael J. AckermanMAMichael J. Ackerman
- 1 October 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 10 (5)
Abstract
Background—: WEMA (Whole-Exome Molecular Autopsy) and surveillance of cardiac channelopathy and cardiomyopathy genes represents the latest molecular autopsy for sudden death in the young (SDY). To date, the majority of WEMA has been performed on the SDY case only. Methods and Results—: We performed whole-exome sequencing and nucleotide-level coverage analysis on 28 SDY cases (18.4±7.8 years) and their parents to determine the inheritance patterns of ultrarare, nonsynonymous variants in 99 sudden death–susceptibility genes. Nonsynonymous variants were adjudicated using the American College of Medical Genetics guidelines. Overall, 17 sudden death–susceptibility gene variants were identified in 12 of 28 (43%) SDY cases. On the basis of the American College of Medical Genetics guidelines, 6 of 28 (21%) cases had a pathogenic or likely pathogenic nonsynonymous variant with 3 (50%) being de novo. Two nonsynonymous variants would not have been elevated to likely pathogenic status without knowing their de novo status. Whole-exome sequencing reached a read depth of 10× across 90% of nucleotides within sudden death–susceptibility genes in 100% of parental exomes from fresh blood draw, compared with only 82% of autopsy-sourced SDY exomes. Conclusions—: An SDY-parent, trio-based WEMA may be an effective way of elucidating a monogenic cause of death and bringing clarity to otherwise ambiguous variants. If other studies confirm this relatively high rate of SDY cases stemming from de novo mutations, then the WEMA should become even more cost-effective given that the decedent’s first-degree relatives should only need minimal cardiological evaluation. In addition, autopsy-sourced DNA demonstrated strikingly lower whole-exome sequencing coverage than DNA from fresh blood draw.Keywords
This publication has 29 references indexed in Scilit:
- Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic settingEuropean Journal of Human Genetics, 2016
- A Prospective Study of Sudden Cardiac Death among Children and Young AdultsNew England Journal of Medicine, 2016
- Whole-Exome Molecular Autopsy After Exertion-Related Sudden Unexplained Death in the YoungCirculation: Cardiovascular Genetics, 2016
- Post-mortem Whole Exome Sequencing with Gene-Specific Analysis for Autopsy-Negative Sudden Unexplained Death in the Young: A Case SeriesPediatric Cardiology, 2014
- Exome analysis–based molecular autopsy in cases of sudden unexplained death in the youngHeart Rhythm, 2014
- HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia SyndromesHeart Rhythm, 2013
- Hypertrophic cardiomyopathyThe Lancet, 2013
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)EP Europace, 2011
- Epidemiology of Sudden Cardiac Death: Clinical and Research ImplicationsProgress in Cardiovascular Diseases, 2008
- Causes of sudden cardiac death in young AustraliansMedical Journal of Australia, 2004